Gilead Sciences, Inc. (GILD) Misses Q4 EPS by 8c, Sales Top Slightly
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $147.60 --0%
Financial Fact:
Net income attributable to Gilead: 3.33B
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Net income attributable to Gilead: 3.33B
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.97, $0.08 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.18 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Coty stock tumbles as lack of visibility, RBC downgrade overshadow Q4 beat
- Sysco adds two directors, targets AI-driven cost savings of $100M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
